| Ms Susan T Reece, NP | |
|
50 Irving St Nw, District Of Columbia, DC 20422 | |
| (202) 745-8000 | |
| Not Available |
| Full Name | Ms Susan T Reece |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 50 Irving St Nw, District Of Columbia, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104917665 | NPI | - | NPPES |
| 0024052945 | Other | VA | NURSE PRACTITIONER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 0024052945 (Virginia) | Primary |
| 363LF0000X | Nurse Practitioner - Family | 0024052945 (Virginia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Susan T Reece, NP 800 Seneca Road, Richmond, VA 23226 Ph: (804) 673-0597 | Ms Susan T Reece, NP 50 Irving St Nw, District Of Columbia, DC 20422 Ph: (202) 745-8000 |
News Archive
An international research consortium co-led by Andrea L. Gropman, M.D., at Children's National Hospital has received $5 million in federal funding as part of an overall effort to better understand rare diseases and accelerate potential treatments to patients.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the most recent publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
Transplanting a pair of kidneys with limited function into one patient can be just as successful as the standard procedure in which a patient receives a single kidney, according to new research at Wake Forest University Baptist Medical Center.
› Verified 2 days ago
Adrianne Sapienza, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 11 Michigan Ave Nw, District Of Columbia, DC 20010 Phone: 888-884-2327 |